In our diabetic patients with stages 3–4 CKD and Hb < 10 g/dL, we observed that higher HbA1c levels were not predictive of inferior clinical outcomes, and similar results were observed with different HbA1c classifications. The gene discussed is GSTM1; the disease is chronic kidney disease.